0001628656-18-000004.txt : 20180921
0001628656-18-000004.hdr.sgml : 20180921
20180921122508
ACCESSION NUMBER: 0001628656-18-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180919
FILED AS OF DATE: 20180921
DATE AS OF CHANGE: 20180921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tobin Bernard
CENTRAL INDEX KEY: 0001628656
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26642
FILM NUMBER: 181081047
MAIL ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MYRIAD GENETICS INC
CENTRAL INDEX KEY: 0000899923
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 870494517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
BUSINESS PHONE: 801-584-3600
MAIL ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2018-09-19
0
0000899923
MYRIAD GENETICS INC
MYGN
0001628656
Tobin Bernard
320 WAKARA WAY
SALT LAKE CITY
UT
84108
0
1
0
0
President Crescendo BioScience
Common Stock
2018-09-19
4
A
0
35000
0.0
A
177551
D
Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 25, 2019, 25% on September 25, 2020, 25% on September 25, 2021, and 25% on September 25, 2022.
By: Richard Marsh For: Bernard Francis Tobin
2018-09-21